English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18265/20495 (89%)
Visitors : 8363555      Online Users : 1128
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34890


    標題: Antioxidant and anti-α-glucosidase activities of biotransformable dragon's blood via predicted data mining approach
    作者: Wu, Jiumn-Yih
    Ding, Hsiou-Yu
    Wang, Tzi-Yuan
    Cai, Cheng-Zhi
    Chang, Te-Sheng
    貢獻者: Natl Quemoy Univ, Dept Food Sci
    Chia Nan Univ Pharm & Sci, Dept Cosmet Sci
    Acad Sinica, Biodivers Res Ctr
    Natl Univ Tainan, Dept Biol Sci & Technol
    關鍵字: Bacillus megaterium
    Tyrosinase
    Anti-alpha-glucosidase
    Antioxidant
    Biotransformation
    Dracaena cochinchinensis
    Dragon's blood
    Loureirin
    日期: 2023
    上傳時間: 2024-12-25 11:05:09 (UTC+8)
    出版者: ELSEVIER SCI LTD
    摘要: Bacillus megaterium tyrosinase (BmTYR) has been proven an applicable biocatalyst in the ortho-hydroxylation of flavonoids, which usually possess higher antioxidant activity than their precursors. With a predicted data mining approach (PDMA), putative novel bioactive flavonoids from known precursors may be good candidates for biotransformation by BmTYR. Two flavonoid precursors (loureirin A and loureirin B) were confirmed via this approach, which are the commercial constituents of the Chinese medicine dragon's blood. These two flavonoids were then biotransformed by BmTYR for validation. The results found two novel flavonoids (3 ' -hydroxyloureirin A and 3 '-hydroxyloureirin B), which gained 2.5 and 1.6 times of the antioxidant activity of ascorbic acid, respectively. In addition, all four flavonoids-loureirin A, loureirin B, and the two 3 '-hydroxyl derivatives-possessed 4-22 times the anti-alpha-glucosidase activity of acarbose, a clinical anti-diabetes drug. A further kinetic analysis revealed that the inhibition mode of the four alpha-glucosidase inhibitors was non-competitive, and their kinetic constants (Ki values) were 64.3 +/- 2.5 mu M, 308.7 +/- 10.4 mu M, 69.4 +/- 2.8 mu M, and 325.3 +/- 12.6 mu M, respectively. The high antioxidant and anti-a-glucosidase activity suggest that the two novel flavonoids have potential future applications in pharmacology and biotechnology.
    關聯: Process Biochemistry, v.130, pp.166-173
    Appears in Collections:[化妝品應用與管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML130View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback